KYNAM CAPITAL MANAGEMENT, LP Travere Therapeutics, Inc. Transaction History

KYNAM CAPITAL MANAGEMENT, LP portfolio value:

$10.26M
portfolio value

KYNAM CAPITAL MANAGEMENT, LP quarter portfolio value change:

+1.69%
quarter

Travere Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -66.26% -818.42K shares -19.66M $24.64 416.72K
Q2 2022 share Increase +41.82% 364.23K shares 7.48M $24.23 1.23M
Q1 2022 share Increase +378.26% 688.81K shares 16.79M $25.77 870.91K
Q4 2021 share Increase 0.00% 182.10K shares 5.65M $30.31 182.10K